On February 24, a follow-up revealed platelets at 34.0 × 109/L, 1% schistocytes, ADAMTS13 activity at 1.63%, and negative ADAMTS13 inhibitory antibodies, suggesting that TTP was not completely controlled. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.